Antares Pharma, Inc. (ATRS)

EBITDA Growth

-132.59%

Quarterly · Period ending:

ATRS logo

ATRS EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-132.59%
ATRS Quarterly EBITDA YoY % (-40.00% → -132.59%)
High-resolution chart · PNG

ATRS ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. EBITDA Growth — Quarterly
Period endingEBITDA Growth
-132.5854%
562.5215%
39.8526%
105.6965%
960.5517%
8.8075%
134.5843%
533.7237%
82.7381%
-17.3963%
511.1952%
73.8278%
15.2884%
410.3986%
84.5484%
-38.138%
-16.8722%
36.0297%
24.1624%
57.6954%
41.4262%
35.3684%
-5.6885%
-400.2034%
-13.0041%
37.5946%
21.7079%
87.342%
25.2132%
-80.7427%
-9.3968%
-75.7363%
-157.0573%
-8.1931%
-81.5986%
-80.6349%
-11,743.9321%
-4,524.5321%
-173.4963%
-83.0379%
97.8996%
91.3964%
20.6747%
-0.7399%
14.2833%
47.0203%
38.2722%
25.8407%
37.0758%
10.9114%
21.7233%
35.0386%
26.1817%
-177.881%
-34.7724%
-64.905%
-1,039.6649%
26.676%
-35.7023%
18.7089%
86.4907%
28.0663%
3.4852%
-7.9744%
-0.8364%
18.611%
15.1009%
-43.6278%
-36.1912%
11.4561%
90.52%
56.4274%
37.4985%
-6.3775%
-551.0616%
-102.1129%
-33.1203%
29.6637%
-93.609%
-27.6651%
-37.2793%
-64.8099%
-77.3109%
-65.015%
-90.1089%
-273.9732%
14.0895%
26.2868%
-83.278%
67.5923%
14.2857%
8.3333%
55.5556%
-1,048.0536%
-40%
-50%
-28.5714%
43.9698%
-66.6667%
-33.3333%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.